AU2002222252A1 - Nitric oxide synthase inhibitor phosphate salt - Google Patents

Nitric oxide synthase inhibitor phosphate salt

Info

Publication number
AU2002222252A1
AU2002222252A1 AU2002222252A AU2002222252A AU2002222252A1 AU 2002222252 A1 AU2002222252 A1 AU 2002222252A1 AU 2002222252 A AU2002222252 A AU 2002222252A AU 2002222252 A AU2002222252 A AU 2002222252A AU 2002222252 A1 AU2002222252 A1 AU 2002222252A1
Authority
AU
Australia
Prior art keywords
nitric oxide
phosphate salt
oxide synthase
synthase inhibitor
inhibitor phosphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002222252A
Other versions
AU2002222252B2 (en
Inventor
David Box
David Colclough
Iain Gillies
Michael Simon Loft
Rebecca Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0031179.5A external-priority patent/GB0031179D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2002222252A1 publication Critical patent/AU2002222252A1/en
Application granted granted Critical
Publication of AU2002222252B2 publication Critical patent/AU2002222252B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002222252A 2000-12-21 2001-12-17 Nitric oxide synthase inhibitor phosphate salt Ceased AU2002222252B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0031179.5 2000-12-21
GBGB0031179.5A GB0031179D0 (en) 2000-12-21 2000-12-21 Nitric oxide synthase inhibitors
PCT/GB2001/005596 WO2002050021A1 (en) 2000-12-21 2001-12-17 Nitric oxide synthase inhibitor phosphate salt

Publications (2)

Publication Number Publication Date
AU2002222252A1 true AU2002222252A1 (en) 2002-09-05
AU2002222252B2 AU2002222252B2 (en) 2005-02-24

Family

ID=9905536

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2002222252A Ceased AU2002222252B2 (en) 2000-12-21 2001-12-17 Nitric oxide synthase inhibitor phosphate salt
AU2225202A Pending AU2225202A (en) 2000-12-21 2001-12-17 Nitric oxide synthase inhibitor phosphate salt

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2225202A Pending AU2225202A (en) 2000-12-21 2001-12-17 Nitric oxide synthase inhibitor phosphate salt

Country Status (19)

Country Link
US (1) US7317040B2 (en)
EP (1) EP1351929A1 (en)
JP (1) JP3971704B2 (en)
KR (1) KR100853049B1 (en)
CN (1) CN100369894C (en)
AR (1) AR031944A1 (en)
AU (2) AU2002222252B2 (en)
BR (1) BR0116369A (en)
CA (1) CA2432121C (en)
CZ (1) CZ301458B6 (en)
GB (1) GB0031179D0 (en)
HU (1) HUP0500736A3 (en)
IL (1) IL156305A0 (en)
MX (1) MXPA03005698A (en)
NO (1) NO328982B1 (en)
NZ (1) NZ526563A (en)
PL (1) PL207158B1 (en)
WO (1) WO2002050021A1 (en)
ZA (1) ZA200304683B (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0214147D0 (en) * 2002-06-19 2002-07-31 Glaxo Group Ltd Formulations
PL375557A1 (en) * 2002-08-23 2005-11-28 Pharmacia Corporation Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid
TWI328009B (en) 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
GB0316290D0 (en) 2003-07-11 2003-08-13 Glaxo Group Ltd Novel compounds
AR049384A1 (en) 2004-05-24 2006-07-26 Glaxo Group Ltd PURINA DERIVATIVES
TWI307630B (en) 2004-07-01 2009-03-21 Glaxo Group Ltd Immunoglobulins
GB0418045D0 (en) 2004-08-12 2004-09-15 Glaxo Group Ltd Compounds
ATE517908T1 (en) 2005-01-10 2011-08-15 Glaxo Group Ltd ANDROSTAN-17-ALPHA-CARBONATE DERIVATIVES FOR USE IN THE TREATMENT OF ALLERGIC AND INFLAMMATORY CONDITIONS
UY29440A1 (en) 2005-03-25 2006-10-02 Glaxo Group Ltd NEW COMPOUNDS
PE20061193A1 (en) 2005-03-25 2006-12-02 Glaxo Group Ltd DERIVATIVES OF 3,4-DIHYDROPYRIMIDO [4,5-d] PYRIMIDIN-2- [1H] -0NA AS KINASE INHIBITORS p38
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds
TW200730498A (en) 2005-12-20 2007-08-16 Glaxo Group Ltd Compounds
BRPI0710240A2 (en) 2006-04-20 2011-08-09 Glaxo Group Ltd compound, use of a compound, method for treating a human or animal patient with a condition or disease, pharmaceutical composition, combination, and process for preparing a compound
GB0611587D0 (en) 2006-06-12 2006-07-19 Glaxo Group Ltd Novel compounds
DK2046787T3 (en) 2006-08-01 2011-07-18 Glaxo Group Ltd Pyrazolo [3,4-B] pyridine compounds, and their use as PDE4 inhibitors
WO2008147445A2 (en) * 2006-11-09 2008-12-04 University Of Maryland, Baltimore Use of 5,6-dimethylxanthenone-4-acetic acid as an antimicrobial agent
AR065804A1 (en) 2007-03-23 2009-07-01 Smithkline Beecham Corp COMPOSITE OF INDOL CARBOXAMIDE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND USE OF THIS COMPOUND TO PREPARE A MEDICINAL PRODUCT
KR20160129109A (en) 2008-05-23 2016-11-08 아미라 파마슈티칼스 인코포레이티드 5-lipoxygenase-activating protein inhibitor
WO2009147187A1 (en) 2008-06-05 2009-12-10 Glaxo Group Limited 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases
JP5502077B2 (en) 2008-06-05 2014-05-28 グラクソ グループ リミテッド New compounds
WO2010094643A1 (en) 2009-02-17 2010-08-26 Glaxo Group Limited Quinoline derivatives and their uses for rhinitis and urticaria
EP2406255B1 (en) 2009-03-09 2015-04-29 Glaxo Group Limited 4-oxadiazol-2-yl-indazoles as inhibitors of pi3 kinases
JP2012520257A (en) 2009-03-10 2012-09-06 グラクソ グループ リミテッド Indole derivatives as IKK2 inhibitors
EP2408769A1 (en) 2009-03-17 2012-01-25 Glaxo Group Limited Pyrimidine derivatives used as itk inhibitors
WO2010107957A2 (en) 2009-03-19 2010-09-23 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
JP2012520683A (en) 2009-03-19 2012-09-10 メルク・シャープ・エンド・ドーム・コーポレイション RNA interference-mediated inhibition of connective tissue growth factor (CTGF) gene expression using small interfering nucleic acids (siNA)
JP2012520686A (en) 2009-03-19 2012-09-10 メルク・シャープ・エンド・ドーム・コーポレイション RNA interference-mediated inhibition of signal transduction transcription factor 6 (STAT6) gene expression using small interfering nucleic acids (siNA)
CN102439151A (en) 2009-03-19 2012-05-02 默沙东公司 Rna interference mediated inhibition of btb and cnc homology 1, basic leucine zipper transcription factor 1 (bach 1) gene expression using short interfering nucleic acid (sina) sequence listing
JP2012521764A (en) 2009-03-27 2012-09-20 メルク・シャープ・エンド・ドーム・コーポレイション RNA interference-mediated inhibition of thymic stromal lymphocyte formation factor (TSLP) gene expression using small interfering nucleic acids (siNA)
WO2010111464A1 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF APOPTOSIS SIGNAL-REGULATING KINASE 1 (ASK1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
EP2411018A2 (en) 2009-03-27 2012-02-01 Merck Sharp&Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF THE NERVE GROWTH FACTOR BETA CHAIN (NGFß) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (SINA)
SG174581A1 (en) 2009-03-27 2011-10-28 Merck Sharp & Dohme RNA INTERFERENCE MEDIATED INHIBITION OF THE INTERCELLULAR ADHESION MOLECULE 1 (ICAM-1)GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2010111471A2 (en) 2009-03-27 2010-09-30 Merck Sharp & Dohme Corp. RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 1 (STAT1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
JP2012524754A (en) 2009-04-24 2012-10-18 グラクソ グループ リミテッド Pyrazole and triazolcarboxamides as CRAC channel inhibitors
US8399436B2 (en) 2009-04-24 2013-03-19 Glaxo Group Limited N-pyrazolyl carboxamides as CRAC channel inhibitors
JO3025B1 (en) 2009-04-30 2016-09-05 Glaxo Group Ltd Oxazole substituted indazoles as pi3 - kinase inhibitors
EP2507226A1 (en) 2009-12-03 2012-10-10 Glaxo Group Limited Novel compounds
JP2013512880A (en) 2009-12-03 2013-04-18 グラクソ グループ リミテッド Indazole derivatives as PI3-kinase inhibitors
JP2013512879A (en) 2009-12-03 2013-04-18 グラクソ グループ リミテッド Benzpyrazole derivatives as inhibitors of PI3 kinase
WO2011084316A2 (en) 2009-12-16 2011-07-14 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
TWI375671B (en) * 2010-03-01 2012-11-01 Univ China Medical Pharmaceutical compositions containing brazilin for inhibiting expression of cytokines of t helper cell type ii and/or inhibiting expression of chemokines and uses of the same
WO2011110575A1 (en) 2010-03-11 2011-09-15 Glaxo Group Limited Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
GB201007203D0 (en) 2010-04-29 2010-06-16 Glaxo Group Ltd Novel compounds
DK2614058T3 (en) 2010-09-08 2015-09-28 Glaxosmithkline Ip Dev Ltd Polymorphs, and the salts of N- [5- [4- (5 - {[(2R, 6S) -2,6-dimethyl-4-morpholinyl] methyl} -1,3-oxazol-2-yl) -1H-indazole -6-yl] -2- (methyloxy) -3-pyridinyl] methanesulfonamide.
ES2602972T3 (en) 2010-09-08 2017-02-23 Glaxosmithkline Intellectual Property Development Limited Indazole derivatives for use in the treatment of influenza virus infection
WO2012035055A1 (en) 2010-09-17 2012-03-22 Glaxo Group Limited Novel compounds
JP5795643B2 (en) 2010-10-21 2015-10-14 グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ Pyrazole compounds acting on allergic, immune and inflammatory conditions
US9149462B2 (en) 2010-10-21 2015-10-06 Glaxo Group Limited Pyrazole compounds acting against allergic, inflammatory and immune disorders
GB201018124D0 (en) 2010-10-27 2010-12-08 Glaxo Group Ltd Polymorphs and salts
JP2012140390A (en) * 2011-01-06 2012-07-26 Sumitomo Chemical Co Ltd METHOD FOR PRODUCING α-AMINO-γ-BUTYROLACTONE
GB201104153D0 (en) 2011-03-11 2011-04-27 Glaxo Group Ltd Novel compounds
EP2683716A1 (en) 2011-03-11 2014-01-15 Glaxo Group Limited Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
CN102344397B (en) * 2011-08-23 2013-09-04 浙江升华拜克生物股份有限公司 Method for purifying valnemulin hydrochloride
BR112016003229A8 (en) 2013-09-22 2020-02-04 Calitor Sciences Llc compound, pharmaceutical composition, and, use of a compound or pharmaceutical composition
WO2015148867A1 (en) 2014-03-28 2015-10-01 Calitor Sciences, Llc Substituted heteroaryl compounds and methods of use
CN107072976A (en) 2014-05-12 2017-08-18 葛兰素史克知识产权第二有限公司 The pharmaceutical composition for including Danirixin for treating communicable disease
WO2017044434A1 (en) 2015-09-11 2017-03-16 Sunshine Lake Pharma Co., Ltd. Substituted heteroaryl compounds and methods of use
WO2017214159A1 (en) * 2016-06-06 2017-12-14 The Regents Of The University Of California A host cell modified to produce lactams
JP7254076B2 (en) 2017-11-19 2023-04-07 サンシャイン・レイク・ファーマ・カンパニー・リミテッド Substituted heteroaryl compounds and methods of use
WO2019143874A1 (en) 2018-01-20 2019-07-25 Sunshine Lake Pharma Co., Ltd. Substituted aminopyrimidine compounds and methods of use
CN109369432B (en) * 2018-11-02 2021-06-25 永农生物科学有限公司 Preparation method of (S) -4-chloro-2-aminobutyrate
EP4125919A1 (en) 2020-03-26 2023-02-08 GlaxoSmithKline Intellectual Property Development Limited Cathepsin inhibitors for preventing or treating viral infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2989010B2 (en) 1994-06-15 1999-12-13 ザ、ウェルカム、ファンデーション、リミテッド Enzyme inhibitors
JPH10502362A (en) 1994-07-04 1998-03-03 シエーリング アクチエンゲゼルシヤフト Low-dose steroid tablets containing gallic acid ester as antioxidant, method for preparing the same and use thereof
MY117948A (en) * 1997-01-13 2004-08-30 Glaxo Group Ltd Nitride oxide synthase inhibitors.
OA11901A (en) 1998-03-11 2006-04-10 Searle & Co Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors.
GB9810299D0 (en) * 1998-05-15 1998-07-15 Glaxo Group Ltd Use of nitric oxide synthase inhibitors

Similar Documents

Publication Publication Date Title
AU2002222252A1 (en) Nitric oxide synthase inhibitor phosphate salt
AU2225202A (en) Nitric oxide synthase inhibitor phosphate salt
AU4430599A (en) Inhibitors of nitric oxide synthase
HK1034241A1 (en) Nitric oxide synthase inhibitors
HK1050521A1 (en) Amidino compounds useful as nitric oxide synthase inhibitors
AU2001258771A1 (en) -secretase inhibitors
CY2263B1 (en) Nitric oxide synthase inhibitors
AU2625201A (en) Glycogen synthase kinase-3 inhibitors
AU2002213048A1 (en) Phosphate transport inhibitors
ZA991894B (en) Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors.
AU2001236052A1 (en) Urease inhibitors
AU2001259354A1 (en) Phosphate transport inhibitors
IL153230A0 (en) Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
AU2001270200A1 (en) Fatty acid synthase inhibitors
AU2001281059A1 (en) Fatty acid synthase inhibitors
AU2002224550A1 (en) Corrosion inhibitors
AU2001282746A1 (en) Novel phenylheteroazetidines, useful as nitric oxide synthase inhibitors
AU2001271531A1 (en) Fatty acid synthase inhibitors
GB9810299D0 (en) Use of nitric oxide synthase inhibitors
AU2002350575A1 (en) Selective neuronal nitric oxide synthase inhibitors
AU1539399A (en) Inhibitors of nitric oxide synthase
AU2001271718A1 (en) Fatty acid synthase inhibitors
AU2001284705A1 (en) Fatty acid synthase inhibitors
AU2001291160A1 (en) Fatty acid synthase inhibitors
AU4446500A (en) 5,7-bicyclic amidine derivatives useful as nitric oxide synthase inhibitors